Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Oakley GJ 3rd"'
Autor:
Oakley GJ 3rd, Chiosea SI
Publikováno v:
Journal of Thoracic Oncology; 2011 Aug, Vol. 6 Issue 8, p1407-1412, 6p
Autor:
Attia S; Mayo Clinic, Jacksonville, FL 32224, USA., Villalobos V; School of Medicine, University of Colorado Denver, Aurora, CO 80045, USA., Hindi N; Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.; Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.; Hospital General de Villalba, 28400 Madrid, Spain., Wagner AJ; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA., Chmielowski B; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA 90024, USA., Oakley GJ 3rd; Eli Lilly and Company, Indianapolis, IN 46255, USA., Peterson PM; Eli Lilly and Company, Indianapolis, IN 46255, USA., Ceccarelli M; Eli Lilly and Company, Indianapolis, IN 46255, USA., Jones RL; Institute of Cancer Research, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK., Dickson MA; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Weill Cornell Medical College, New York, NY 10065, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Oct 06; Vol. 15 (19). Date of Electronic Publication: 2023 Oct 06.
Autor:
Borthakur G; The University of Texas MD Anderson Cancer Center, Houston, Texas., Martinelli G; Department of Specialized, Diagnostic, and Experimental Medicine, University of Bologna, Bologna, Italy., Raffoux E; Saint Louis Hospital, Paris, France., Chevallier P; Central University Research Hospital (CHRU) De Nantes, Hotel-Dieu, Nantes, France., Chromik J; University Hospital Frankfurt, Frankfurt am Main, Germany., Lithio A; Eli Lilly and Company, Indianapolis, Indiana., Smith CL; Eli Lilly and Company, Surrey, United Kingdom., Yuen E; Eli Lilly and Company, Surrey, United Kingdom., Oakley GJ 3rd; Eli Lilly and Company, Indianapolis, Indiana., Benhadji KA; Eli Lilly and Company, Indianapolis, Indiana., DeAngelo DJ; Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Cancer [Cancer] 2021 Feb 01; Vol. 127 (3), pp. 372-380. Date of Electronic Publication: 2020 Oct 27.
Autor:
Martín-Broto J; University Hospital Virgen del Rocio/Institute of Biomedicine of Seville, Seville, Spain., Pousa AL; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Brohl AS; H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Van Tine BA; Washington University School of Medicine, St. Louis, Missouri., Powers B; University of Kansas Medical Center, Kansas City, Kansas., Stacchiotti S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Blay JY; Centre Léon Bérard, Lyon, France., Hu JS; Keck School of Medicine of University of Southern California, Los Angeles, California., Oakley GJ 3rd; Eli Lilly and Company, Indianapolis, Indiana., Wang H; Eli Lilly and Company, Indianapolis, Indiana., Szpurka AM; Eli Lilly and Company, Indianapolis, Indiana., Levy DE; Syneos Health, Morrisville, North Carolina., Mo G; Eli Lilly and Company, Indianapolis, Indiana.; Metrum Research Group, Tariffville, Connecticut., Ceccarelli M; Eli Lilly and Company, Sesto Fiorentino, Florence, Italy., Jones RL; Royal Marsden Hospital/Institute of Cancer Research, London, United Kingdom. robin.jones4@nhs.net.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Jan; Vol. 20 (1), pp. 132-141. Date of Electronic Publication: 2020 Nov 11.
Autor:
Goldman JW; Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, United States., Mazieres J; Thoracic Oncology Department, Toulouse University Hospital, Paul Sabatier University, Toulouse, France., Barlesi F; Multidisciplinary Oncology and Innovative Therapies Department, Aix-Marseille University, INSERM, CNRS, CRCM, Assistance Publque Hôspitaux de Marseille (AP-HM), Marseille, France., Dragnev KH; Department of Medicine, Norris Cotton Cancer Center, Dartmouth-Hitchcock, Lebanon, NH, United States., Koczywas M; Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA, United States., Göskel T; Department of Internal Medical Sciences, Ege University, (Bornova), Izmir, Turkey., Cortot AB; Thoracic Oncology Department, University of Lille, CHU Lille, Lille, France., Girard N; Respiratory Medicine Department, Hospices Civils de Lyon, University of Lyon, Lyon, France., Wesseler C; Department of Thoracic Oncology, Asklepios Klinikum Harburg, Hamburg, Germany., Bischoff H; Department of Thoracic Oncology, Thoraxklinik-Heidelberg, Heidelberg, Germany., Nadal E; Department of Medical Oncology, Catalan Institute of Oncology, (L'Hospitalet), Barcelona, Spain., Park K; Department of Hematology-Oncology, Samsung Medical Center, Seoul, South Korea., Lu S; Lung Tumor Medical (Cancer) Center, Shanghai Chest Hospital, Shanghai (Jiao Tong University), Shanghai, China., Taus A; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain., Cobo M; Medical Oncology Department, Hospital Regional Universitario Málaga, IBIMA, Málaga, Spain., Estrem ST; Eli Lilly and Company, Indianapolis, IN, United States., Wijayawardana SR; Eli Lilly and Company, Indianapolis, IN, United States., Turner K; Eli Lilly and Company, Indianapolis, IN, United States., Oakley GJ 3rd; Eli Lilly and Company, Indianapolis, IN, United States., Hurt KC; Eli Lilly and Company, Indianapolis, IN, United States., Chiang AY; Eli Lilly and Company, Indianapolis, IN, United States., Hossain AM; Eli Lilly and Company, Indianapolis, IN, United States., John WJ; Eli Lilly and Company, Indianapolis, IN, United States., Paz-Ares L; Department of Medicine, Hospital Universitario 12 de Octubre, CNIO and Universidad Complutense, Madrid, Spain.
Publikováno v:
Frontiers in oncology [Front Oncol] 2020 Oct 26; Vol. 10, pp. 578756. Date of Electronic Publication: 2020 Oct 26 (Print Publication: 2020).
Autor:
Even C; Drug Development Department (DITEP), Institut Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant, 94800, Villejuif Cedex, France., Lassen U; The Finsen Centre, Rigshospitalet, Copenhagen, Denmark., Merchan J; University of Miami Miller School of Medicine, Miami, FL, USA., Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; INSERM U900 Research Unit, Saint-Cloud, France.; Paris-Saclay University, Paris, France., Soria JC; Drug Development Department (DITEP), Institut Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant, 94800, Villejuif Cedex, France.; University Paris-Sud, Orsay, France., Ferte C; Drug Development Department (DITEP), Institut Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant, 94800, Villejuif Cedex, France., Ricci F; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Diener JT; Eli Lilly and Company, Indianapolis, IN, USA., Yuen E; Eli Lilly and Company, Indianapolis, IN, USA., Smith C; Eli Lilly and Company, Indianapolis, IN, USA., Oakley GJ 3rd; Eli Lilly and Company, Indianapolis, IN, USA., Benhadji KA; Eli Lilly and Company, Indianapolis, IN, USA., Massard C; Drug Development Department (DITEP), Institut Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant, 94800, Villejuif Cedex, France. christophe.massard@gustaveroussy.fr.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2020 Apr; Vol. 38 (2), pp. 402-409. Date of Electronic Publication: 2019 Apr 06.
Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours.
Autor:
Mir O; Institut Gustave Roussy Cancer Campus, Drug Development Department, Villejuif Cedex, France., Azaro A; Molecular Therapeutics Research Unit, Department of Medical Oncology, Vall D'Hebron University Hospital, and Pharmacology Department, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Merchan J; University of Miami, Sylvester Comprehensive Cancer Center, United States., Chugh R; University of Michigan, United States., Trent J; University of Miami, Sylvester Comprehensive Cancer Center, United States., Rodon J; MD Anderson Cancer Center, United States., Ohnmacht U; Eli Lilly and Company, United States., Diener JT; Eli Lilly and Company, United States., Smith C; Eli Lilly and Company, United Kingdom., Yuen E; Eli Lilly and Company, United Kingdom., Oakley GJ 3rd; Eli Lilly and Company, United States., Le Cesne A; Institut Gustave Roussy Cancer Campus, Drug Development Department, Villejuif Cedex, France., Soria JC; Institut Gustave Roussy Cancer Campus, Drug Development Department, Villejuif Cedex, France., Benhadji KA; Eli Lilly and Company, United States., Massard C; Institut Gustave Roussy Cancer Campus, Drug Development Department, Villejuif Cedex, France. Electronic address: christophe.massard@gustaveroussy.fr.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2018 Nov; Vol. 103, pp. 88-97. Date of Electronic Publication: 2018 Sep 12.
Autor:
Lowery CD; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Blosser W; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Dowless M; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Knoche S; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Stephens J; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Li H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Surguladze D; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Loizos N; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Luffer-Atlas D; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Oakley GJ 3rd; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Guo Q; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Iyer S; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Rubin BP; Department of Pathology, Robert J Tomsich Pathology and Laboratory Medicine Institute and Cleveland Clinic, Cleveland, Ohio.; Department of Cancer Biology, Robert J Tomsich Pathology and Laboratory Medicine Institute and Cleveland Clinic, Cleveland, Ohio., Stancato L; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana. stancato_louis@lilly.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Feb 15; Vol. 24 (4), pp. 847-857. Date of Electronic Publication: 2017 Nov 30.
Autor:
Oakley GJ 3rd; Department of Pathology, Joan C Edwards School of Medicine at Marshall University, United States; Eli Lilly and Company, United States. Electronic address: goakley@marshall.edu., Denning KL; Department of Pathology, Joan C Edwards School of Medicine at Marshall University, United States., Graffeo V; Department of Pathology, Joan C Edwards School of Medicine at Marshall University, United States., Griswold DC; Department of Pathology, Joan C Edwards School of Medicine at Marshall University, United States., Davis AR; Department of Pathology, Joan C Edwards School of Medicine at Marshall University, United States., Brown LG; Department of Pathology, Joan C Edwards School of Medicine at Marshall University, United States.
Publikováno v:
Pathology, research and practice [Pathol Res Pract] 2016 Nov; Vol. 212 (11), pp. 995-1003. Date of Electronic Publication: 2016 Aug 22.
Autor:
Prasad C; Division of Endocrinology, Diabetes, and Metabolism, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Oakley GJ 3rd; Department of Pathology, Marshall University, Huntington, WV, USA., Yip L; Division of Endocrine Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Coyne C; Division of Endocrinology, Diabetes, and Metabolism, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Rangaswamy B; Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Dixit SB; Division of Endocrinology, Diabetes, and Metabolism, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Publikováno v:
SAGE open medical case reports [SAGE Open Med Case Rep] 2014 Oct 06; Vol. 2, pp. 2050313X14553520. Date of Electronic Publication: 2014 Oct 06 (Print Publication: 2014).